VentriPoint Diagnostics Ltd. (VPT.V)
CAD 0.1
(11.11%)
CAD 0.1
(11.11%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -4.93 Million CAD | -0.4% |
| 2022 | -4.91 Million CAD | -32.17% |
| 2021 | -3.71 Million CAD | -96.68% |
| 2020 | -1.88 Million CAD | 42.45% |
| 2019 | -3.28 Million CAD | 14.14% |
| 2018 | -3.82 Million CAD | -12.71% |
| 2017 | -3.39 Million CAD | -64.5% |
| 2016 | -2.06 Million CAD | -2.76% |
| 2015 | -2 Million CAD | -2.58% |
| 2014 | -1.95 Million CAD | 40.82% |
| 2013 | -3.3 Million CAD | 32.95% |
| 2012 | -4.92 Million CAD | -21.39% |
| 2011 | -4.06 Million CAD | -54.63% |
| 2010 | -2.62 Million CAD | -42.56% |
| 2009 | -1.84 Million CAD | 63.58% |
| 2008 | -5.05 Million CAD | -220.04% |
| 2007 | -1.58 Million CAD | -3665.46% |
| 2006 | -41.97 Thousand CAD | 59.47% |
| 2005 | -103.56 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -1.17 Million CAD | 5.44% |
| 2024 Q2 | -1.38 Million CAD | -17.84% |
| 2023 Q1 | -1.37 Million CAD | -23.72% |
| 2023 FY | -4.93 Million CAD | -0.4% |
| 2023 Q3 | -1.18 Million CAD | -5.42% |
| 2023 Q4 | -1.24 Million CAD | -4.57% |
| 2023 Q2 | -1.12 Million CAD | 18.24% |
| 2022 Q1 | -1.01 Million CAD | 14.31% |
| 2022 Q3 | -1.43 Million CAD | -6.2% |
| 2022 Q4 | -1.11 Million CAD | 22.22% |
| 2022 FY | -4.91 Million CAD | -32.17% |
| 2022 Q2 | -1.34 Million CAD | -32.15% |
| 2021 Q2 | -891.3 Thousand CAD | -0.21% |
| 2021 Q4 | -1.18 Million CAD | -59.75% |
| 2021 Q3 | -744.81 Thousand CAD | 16.44% |
| 2021 Q1 | -889.45 Thousand CAD | -37.63% |
| 2021 FY | -3.71 Million CAD | -96.68% |
| 2020 Q3 | -571.51 Thousand CAD | -77.94% |
| 2020 Q1 | -350.14 Thousand CAD | 41.05% |
| 2020 FY | -1.88 Million CAD | 42.45% |
| 2020 Q4 | -646.25 Thousand CAD | -13.08% |
| 2020 Q2 | -321.18 Thousand CAD | 8.27% |
| 2019 Q3 | -774.42 Thousand CAD | 11.81% |
| 2019 Q4 | -593.97 Thousand CAD | 23.3% |
| 2019 Q1 | -1.03 Million CAD | -9.86% |
| 2019 FY | -3.28 Million CAD | 14.14% |
| 2019 Q2 | -878.1 Thousand CAD | 15.26% |
| 2018 Q2 | -1.1 Million CAD | -22.68% |
| 2018 FY | -3.82 Million CAD | -12.71% |
| 2018 Q3 | -875.51 Thousand CAD | 20.72% |
| 2018 Q4 | -943.24 Thousand CAD | -7.74% |
| 2018 Q1 | -900.15 Thousand CAD | 12.99% |
| 2017 Q3 | -1.17 Million CAD | -74.66% |
| 2017 Q2 | -675.45 Thousand CAD | -23.21% |
| 2017 Q1 | -548.19 Thousand CAD | -32.2% |
| 2017 FY | -3.39 Million CAD | -64.5% |
| 2017 Q4 | -1.03 Million CAD | 12.31% |
| 2016 FY | -2.06 Million CAD | -2.76% |
| 2016 Q2 | -635.44 Thousand CAD | -9.75% |
| 2016 Q1 | -578.99 Thousand CAD | 8.17% |
| 2016 Q4 | -414.66 Thousand CAD | 7.39% |
| 2016 Q3 | -447.75 Thousand CAD | 29.54% |
| 2015 FY | -2 Million CAD | -2.58% |
| 2015 Q2 | -496.9 Thousand CAD | -9.04% |
| 2015 Q4 | -630.52 Thousand CAD | -77.05% |
| 2015 Q3 | -356.13 Thousand CAD | 28.33% |
| 2015 Q1 | -455.71 Thousand CAD | 33.95% |
| 2014 FY | -1.95 Million CAD | 40.82% |
| 2014 Q3 | -580.81 Thousand CAD | -51.4% |
| 2014 Q1 | -281.22 Thousand CAD | 70.78% |
| 2014 Q2 | -383.63 Thousand CAD | -36.41% |
| 2014 Q4 | -689.98 Thousand CAD | -18.79% |
| 2013 Q4 | -962.35 Thousand CAD | -22.19% |
| 2013 FY | -3.3 Million CAD | 32.95% |
| 2013 Q2 | -723.64 Thousand CAD | 13.28% |
| 2013 Q1 | -834.43 Thousand CAD | 42.3% |
| 2013 Q3 | -787.55 Thousand CAD | -8.83% |
| 2012 Q2 | -1.05 Million CAD | 7.81% |
| 2012 Q4 | -1.44 Million CAD | -8.82% |
| 2012 FY | -4.92 Million CAD | -21.39% |
| 2012 Q1 | -1.14 Million CAD | -23.3% |
| 2012 Q3 | -1.32 Million CAD | -25.68% |
| 2011 Q3 | -1.08 Million CAD | -13.08% |
| 2011 Q1 | -844.41 Thousand CAD | -15.4% |
| 2011 Q2 | -959.05 Thousand CAD | -13.58% |
| 2011 FY | -4.06 Million CAD | -54.63% |
| 2011 Q4 | -930.24 Thousand CAD | 14.22% |
| 2010 Q3 | -785.38 Thousand CAD | -31.15% |
| 2010 Q1 | -286.9 Thousand CAD | 34.29% |
| 2010 Q4 | -731.7 Thousand CAD | 6.83% |
| 2010 FY | -2.62 Million CAD | -42.56% |
| 2010 Q2 | -598.84 Thousand CAD | -108.73% |
| 2009 FY | -1.84 Million CAD | 63.58% |
| 2009 Q4 | -436.6 Thousand CAD | -84.72% |
| 2009 Q1 | -702.24 Thousand CAD | 61.28% |
| 2009 Q2 | -418.55 Thousand CAD | 40.4% |
| 2009 Q3 | -236.36 Thousand CAD | 43.53% |
| 2008 Q3 | -1.24 Million CAD | -12.54% |
| 2008 Q2 | -1.1 Million CAD | -33.26% |
| 2008 Q1 | -829.07 Thousand CAD | 0.69% |
| 2008 FY | -5.05 Million CAD | -220.04% |
| 2008 Q4 | -1.81 Million CAD | -45.88% |
| 2007 Q3 | -344.11 Thousand CAD | -6041.12% |
| 2007 Q1 | -45.72 Thousand CAD | -41.77% |
| 2007 FY | -1.58 Million CAD | -3665.46% |
| 2007 Q4 | -834.8 Thousand CAD | -142.59% |
| 2007 Q2 | -5603.53 CAD | 87.75% |
| 2006 Q1 | -9992.07 CAD | 0.0% |
| 2006 Q3 | 1808.89 CAD | 217.9% |
| 2006 Q2 | -1534.25 CAD | 84.65% |
| 2006 Q4 | -32.25 Thousand CAD | -1883.17% |
| 2006 FY | -41.97 Thousand CAD | 59.47% |
| 2005 FY | -103.56 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Perimeter Medical Imaging AI, Inc. | -20.72 Million CAD | 76.215% |
| Therma Bright Inc. | -3.6 Million CAD | -36.839% |
| Theralase Technologies Inc. | -4.59 Million CAD | -7.319% |